Since these cells are predominantly CD4+ T cells, one possible explanation is that their proliferative responses were stifled by the reduction in expansion of CD4+ CD25+ FoxP3+ T cells during TB treatment as we have demonstrated or simply because our sample size did not have enough power to detect any significant differences in proliferation in that population of cells. Here, FOXP3 is linked to tuberculosis.